Skip to main contentSkip to navigation
Sirius Investors

BIOE Stock: Bio Essence Corporation Stock Price, Analysis & Insights

Get live BIOE stock price $0.25, comprehensive Bio Essence Corporation stock analysis, charts, news, and expert forecast. Real-time BIOE stock data and investment insights.

0.25
0.00%Today
BIOEBio Essence Corporation • Other OTC • Healthcare
Market Cap
10.02M
Volume
691
52W High
0.52
52W Low
0.05

Loading chart data...

Bio Essence Corporation (BIOE) Overview

Bio Essence Corporation (BIOE) is a publicly traded company in the Healthcare sector , specifically within the Drug Manufacturers - Specialty & Generic industry . As of the latest trading session, BIOE trades at $0.25 with a market capitalization of 10.02M . Over the past 52 weeks, BIOE has traded between $0.05 and $0.52 , with the current price positioned at approximately 43% of this range . T...

Key Takeaways

  • Operates in the Healthcare sector (Drug Manufacturers - Specialty & Generic)
  • Market cap: 10.02M
  • Current price: $0.25
  • 52-week range: $0.05 - $0.52
  • P/E ratio: 8.43

Investment Score

Annual (latest period)
Unavailable

A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.

Score unavailable for this asset.

0-39

Defensive posture

40-54

Mixed / wait for confirmation

55-69

Constructive setup

70-100

Attractive zone

Total Score

Value

Cheapness vs fundamentals and cash generation

Quality

Durability of profitability and balance sheet

Momentum

Price trend strength and persistence

Professional usage: treat the score as a ranking and risk-filtering tool, then confirm with earnings revision trend, competitive positioning, and valuation relative to peers before capital allocation.

Company Overview

Bio Essence Corporation is a global enterprise specializing in herbal health, dietary, and nutritional solutions. It supplies healthcare professionals with a diverse range of herbal remedies, offered in various forms such as granules, capsules, pills...

Company Information

CEO
Yin Yan
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
2

Contact Information

Address
8 Studebaker Drive
Country
US

Investment Analysis & Business Insights

Healthcare
Drug Manufacturers - Specialty & Generic

Investment Highlights

Strong presence in the Healthcare sector with established market position

Valuation metrics suggest potential value opportunity (P/E: 8.4)

Higher growth potential with elevated volatility (Beta: 5.98)

Important Investment Considerations

  • All investments carry risk, including potential loss of principal for Bio Essence Corporation shareholders
  • Market volatility can significantly impact stock price, especially for smaller companies
  • Sector-specific risks in Healthcare may affect company performance
  • Past performance does not guarantee future results for Bio Essence Corporation
  • Investors should consider how Bio Essence Corporation fits within their overall portfolio allocation
  • Valuation metrics suggest potential, but require fundamental analysis

Market Cap

10.02M

P/E Ratio (TTM)

8.43

Beta

5.98

Data Sources & Methodology

Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.

About Healthcare Sector

The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.